July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Immunotherapy Plus Chemotherapy Before Surgery Improves Long-Term Survival in NSCLC – Johns Hopkins Medicine International
Jun 11, 2025, 16:12

Immunotherapy Plus Chemotherapy Before Surgery Improves Long-Term Survival in NSCLC – Johns Hopkins Medicine International

Johns Hopkins Medicine International shared a post on LinkedIn:

“Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) — the leading cause of cancer deaths worldwide — improved long-term survival overall compared with chemotherapy alone, according to a landmark study from JohnsHopkins.
‘Just three doses of immunotherapy and chemotherapy showing a survival advantage is a big step forward for patients,’ says Julie Brahmer, M.D., director of thoracic oncology at the Johns Hopkins Kimmel Cancer Center.”

Read “Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival”.

More posts about Johns Hopkins Medicine International on OncoDaily.